The use of nitroxide radical-containing nanoparticles coupled with piperine to protect neuroblastoma SH-SY5Y cells from Aβ-induced oxidative stress

Biomaterials

Volumn 32, Issue 33, 2011, Pages 8605-8612

  Chonpathompikunlert, Pennapa ^a   Yoshitomi, Toru ^a   Han, Junkyu ^a   Isoda, Hiroko ^a   Nagasaki, Yukio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antioxidant; Copolymer; Free radical; In vitro test; Nanoparticle; Neural cell

Indexed keywords

ALZHEIMER; ANTIOXIDANT; ANTIOXIDANT EFFECT; APOPTOTIC CELL DEATH; BIOCHEMICAL TECHNIQUES; CELL LINES; CELL VIABILITY; COMBINATION THERAPY; ELISA ASSAY; GLUTATHIONE PEROXIDASE; HUMAN NEUROBLASTOMA; IN VITRO TEST; IN-VITRO; NEURAL CELLS; NEUROBLASTOMAS; NITROBLUE TETRAZOLIUM; NITROXIDES; POTENTIAL MECHANISM; PROTECTIVE EFFECTS; REACTIVE OXYGEN SPECIES; SCAVENGING ENZYMES;

CELL CULTURE; CELL DEATH; COPOLYMERS; FREE RADICALS; NANOPARTICLES; PEPTIDES;

OXYGEN;

AMYLOID BETA PROTEIN[1-42]; CAMPTOTHECIN; CATALASE; DEOXYRIBOSE; GLUTATHIONE PEROXIDASE; NANOPARTICLE; NITROXIDE; NITROXIDE RADICAL CONTAINING NANOPARTICLE; PIPERINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NITROBLUE TETRAZOLIUM TEST; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALKALOIDS; AMYLOID BETA-PEPTIDES; APOPTOSIS; BENZODIOXOLES; CELL LINE, TUMOR; HUMANS; NANOPARTICLES; NEUROBLASTOMA; NITROGEN OXIDES; OXIDATIVE STRESS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; REACTIVE OXYGEN SPECIES;

EID: 80052967293     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.07.024     Document Type: Article

References (54)

1. Citron M. Alzheimer's disease: treatments in discovery and development. Nat Neurosci 2002, 5:1055-1057.
2. Vila M., Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 2003, 4:365-375.
3. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997, 23:134-147.
4. Praticò D. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 2008, 29:609-615.
5. Carmody R.J., Cotter T.G. Signalling apoptosis: a radical approach. Redox Rep 2001, 6:77-90.
6. Aruoma O.I., Bahorun T., Jen L.S. Neuroprotection by bioactive components in medicinal and food plant extracts. Mutat Res 2003, 544:203-215.
7. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
8. Parihar M.S., Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 2004, 11:456-467.
9. Stegeman J.J., Hahn M.E. Biochemistry and molecular biology of monooxygenase: current perspectives on forms, functions, and regulation of cytochrome P450 in aquatic species?. Aquatic toxicology 1994, 87-206. Lewis, Boca Raton FL. D.C. Malins, G.K. Ostrander (Eds.).
10. Suy S., Mitchell J.B., Samuni A., Mueller S., Kasid U. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Cancer 2005, 103:1302-1313.
11. Zhao Q.L., Fujiwara Y., Kondo T. Mechanism of cell death induction by nitroxide and hyperthermia. Free Radic Biol Med 2006, 40:1131-1143.
12. Simonsen U., Christensen F.H., Buus N.H. The effect of tempol on endothelium dependent vasodilatation and blood pressure. Pharmacol Ther 2009, 122:109-124.
13. Krishna M.C., DeGraff W., Hankovszky O.H., Sár C.P., Kálai T., Jeko J., et al. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J Med Chem 1998, 41:3477-3492.
14. Yoshitomi T., Suzuki R., Mamiya T., Matsui H., Hirayama A., Nagasaki Y. pH-sensitive radical-containing-nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances. Bioconjug Chem 2009, 20:1792-1798.
15. Yoshitomi T., Miyamoto D., Nagasaki Y. Design of core-shell-type nanoparticles carrying stable radicals in the core. Biomacromolecules 2009, 10:596-601.
16. Chonpathompikunlert P., Han J., Toh K., Isoda H., Nagasaki Y. TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity. Eur J Pharmacol 2011, 650:544-549.
17. Marushima A., Suzuki K., Nagasaki Y., Yoshitomi T., Toh K., Tsurushima H., et al. Newly Synthesized radical-containing nanoparticles (RNP) enhance neuroprotection after cerebral ischemia-reperfusion injury. Neurosurgery 2011, 68:1418-1426.
18. Hasani-Ranjbar S., Larijani B., Abdollahi M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets 2009, 8:2-10.
19. Gupta S.K., Bansal P., Bhardwaj R.K., Velpandian T. Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol Res 2000, 41:657-662.
20. D'Hooge R., Pei Y.Q., Raes A., Lebrun P., van Bogaert P.P., de Deyn P.P. Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittelforschung 1996, 46:557-560.
21. Bai Y.F., Xu H. Protective action of piperine against experimental gastric ulcer. Acta Pharmacol Sin 2000, 21:357-359.
22. Lee S.A., Hong S.S., Han X.H., Hwang J.S., Oh G.J., Lee K.S., et al. Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chem Pharm Bull (Tokyo) 2005, 53:832-835.
23. Selvendiran K., Singh J.P., Krishnan K.B., Sakthisekaran D. Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 2003, 74:109-115.
24. Chonpathompikunlert P., Wattanathorn J., Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease. Food Chem Toxicol 2010, 48:798-802.
25. Wattanathorn J., Chonpathompikunlert P., Muchimapura S., Priprem A., Tankamnerdthai O. Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol 2008, 46:3106-3110.
26. Daware M.B., Mujumdar A.M., Ghaskadbi S. Reproductive toxicity of piperine in Swiss albino mice. Planta Med 2000, 66:231-236.
27. Malini T., Manimaran R.R., Arunakaran J., Aruldhas M.M., Govindarajulu P. Effects of piperine on testis of albino rats. J Ethnopharmacol 1999, 64:219-225.
28. Bhat B.G., Chandrasekhara N. Studies on the metabolism of piperine: absorption, tissue distribution and excretion of urinary conjugates in rats. Toxicology 1986, 40:83-92.
29. Isoda H., Koyama A., Oka S., Abe Y. Protective effect of the Chinese medicinal Desert plant Cistanche salsa on human-derived neurotypic SH-SY5Y cells against Alzheimer's disease amyloid-beta-induced toxicity. J Arid Land Stud 2002, 12:77-82.
30. Falasca G.F., Ramachandrula A., Kelley K.A., O'Connor C.R., Reginato A.J. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 1993, 36:105-116.
31. Thamilselvan S., Byer K.J., Hackett R.L., Khan S.R. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 2000, 164:224-229.
32. Halliwell B., Grootveld M., Gutteridge J.M. Methods for the measurement of hydroxyl radicals in biomedical systems: deoxyribose degradation and aromatic hydroxylation. Methods Biochem Anal 1988, 33:59-90.
33. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978, 86:271-278.
34. Goldblith S.A., Proctor B.E. Photometric determination of catalase activity. J Biol Chem 1950, 187:705-709.
35. Wendel A. Enzymatic basis of Detoxication. Glutathione peroxidase 1980, 333-353. Academic Press, New York. W.B. Jakoby (Ed.).
36. Ngamwongsatit P., Banada P.P., Panbangred W., Bhunia A.K. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Methods 2008, 73:211-215.
37. Chonpathompikunlert P., Yoshitomi T., Han J., Toh K., Isoda H., Nagasaki Y. Chemical nanotherapy-nitroxyl radical-containing nanoparticle (RNP) protects neuroblastoma SH-SY5Y cells from Aß-induced oxidative stress. Ther Deliv 2011, 2:585-597.
38. Yamada J., Yoshimura S., Yamakawa H., Sawada M., Nakagawa M., Hara S., et al. Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci Res 2003, 45:1-8.
39. Li Y.P., Bushnell A.F., Lee C.M., Perlmutter L.S., Wong S.K. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 1996, 738:196-204.
40. Guan Z.Z., Yu W.F., Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int 2003, 43:243-249.
41. Miranda S., Opazo C., Larrondo L.F., Munoz F.J., Ruiz F., Leighton F., et al. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Prog Neurobiol 2000, 62:633-648.
42. Liang Q., Smith A.D., Pan S., Tyurin A.V., Kagan V.E., Hastings T.G., et al. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem Pharmacol 2005, 70:1371-1381.
43. Thiemermann C. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation. Crit Care Med 2003, 31:76-84.
44. Yukio Nagasaki Stable radical-containing nanoparticles for anti-oxidative stress disease. Free Radic Res 2009, 43:47.
45. Chelikani P., Fita I., Loewen P.C. Diversity of structures and properties among catalases. Cell Mol Life Sci 2004, 61:192-208.
46. Flohé L. The glutathione peroxidase reaction: molecular basis of the antioxidant function of selenium in mammals. Curr Top Cell Regul 1985, 27:473-478.
47. Mittal R., Gupta R.L. In vitro antioxidant activity of piperine. Methods Find Exp Clin Pharmacol 2000, 22:271-274.
48. Krishnakantha T.P., Lokesh B.R. Scavenging of superoxide anions by spice principles. Indian J Biochem Biophys 1993, 30:133-134.
49. Lee C.S., Han E.S., Kim Y.K. Piperine inhibition of 1-methyl-4-phenylpyridium-induced mitochondrial dysfunction and cell death in PC12 cells. Eur J Pharmacol 2006, 537:37-44.
50. Piyachaturawat P., Glinsukon T., Toskulkao C. Acute and subacute toxicity of piperine in mice, rats and hamsters. Toxicol Lett 1983, 16:351-359.
51. Unchern S., Saito H., Nishiyama N. Selective cytotoxicity of piperine on cultured rat hippocampal neurons in comparison with cultured astrocytes: the possible involvement of lipid peroxidation. Biol Pharm Bull 1997, 20:958-961.
52. Krishna M.C., Russo A., Mitchell J.B., Goldstein S., Dafni H., Samuni A. Do nitroxide antioxidants act as scavengers of O2- or as SOD mimics?. J Biol Chem 1996, 271:26026-26031.
53. Samuni A., Mitchell J.B., DeGraff W., Krishna C.M., Samuni U., Russo A. Nitroxide SOD-mimics: modes of action. Free Radic Res Commun 1991, 12/13:187-194.
54. Ingkaninan K., Temkitthawon P., Chuenchom K., Yuyaem T., Thongnoi W. Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies. J Ethonopharmacol 2003, 89:261-264.